Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1982 Jun;35(6):617–619. doi: 10.1136/jcp.35.6.617

Systemic mastocytosis, myelofibrosis and portal hypertension.

A H Sawers, J Davson, J Braganza, C G Geary
PMCID: PMC497735  PMID: 7085913

Abstract

A case of systemic mastocytosis is described in which the finding on initial presentation was hepatosplenomegaly. No dermatological abnormality was present, and the bone marrow histology originally caused some confusion with primary myelofibrosis. The clinical course and the importance of distinguishing between these two diseases is discussed. The dermatological manifestation of systemic mastocytosis, in the form of urticaria pigmentosa, is well recognised, and alerts the physician to the underlying disease. In the absence of cutaneous signs, however, the diagnosis is less obvious. The case reported had predominantly marrow and splenic involvement by the disease process, giving rise to portal hypertension, and illustrates the problems of diagnosis which can arise.

Full text

PDF
617

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Capron J. P., Lebrec D., Degott C., Chivrac D., Coevoet B., Delobel J. Portal hypertension in systemic mastocytosis. Gastroenterology. 1978 Mar;74(3):595–597. [PubMed] [Google Scholar]
  2. DEMIS D. J. THE MASTOCYTOSIS SYNDROME: CLINICAL AND BIOLOGICAL STUDIES. Ann Intern Med. 1963 Aug;59:194–206. doi: 10.7326/0003-4819-59-2-194. [DOI] [PubMed] [Google Scholar]
  3. GOLDHABER P. HEPARIN ENHANCEMENT OF FACTORS STIMULATING BONE RESORPTION IN TISSUE CULTURE. Science. 1965 Jan 22;147(3656):407–408. doi: 10.1126/science.147.3656.407. [DOI] [PubMed] [Google Scholar]
  4. Gilbert H. S. The spectrum of myeloproliferative disorders. Med Clin North Am. 1973 Mar;57(2):355–393. doi: 10.1016/s0025-7125(16)32287-8. [DOI] [PubMed] [Google Scholar]
  5. Grundfest S., Cooperman A. M., Ferguson R., Benjamin S. Portal hypertension associated with systemic mastocytosis and splenomegaly. Gastroenterology. 1980 Feb;78(2):370–373. [PubMed] [Google Scholar]
  6. MORRIONE T. G. The formation of collagen fibers by the action of heparin on soluble collagen: an electron microscope study. J Exp Med. 1952 Aug;96(2):107–114. doi: 10.1084/jem.96.2.107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Udoji W. C., Razavi S. A. Mast cells and myelofibrosis. Am J Clin Pathol. 1975 Feb;63(2):203–209. doi: 10.1093/ajcp/63.2.203. [DOI] [PubMed] [Google Scholar]
  8. Yam L. T., Yam C. F., Li C. Y. Eosinophilia in systemic mastocytosis. Am J Clin Pathol. 1980 Jan;73(1):48–54. doi: 10.1093/ajcp/73.1.48. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES